The ongoing TOPS study has been examining the use of cannabis as a substitute for opioid-based pain medication by collecting survey data from 2,897 medical cannabis patients. Over 1,600 patients have enrolled in TOPS to date, making it the largest Canadian national longitudinal cannabis study.

Read the full report here.